In vitro, siRNA-mediated sFRP-1 knockdown in triple-negative MDA-MB 468 BC cell lines correlated with increased proliferation and, particularly, with reduced response to paclitaxel [32]. The gene discussed is SFRP1; the disease is breast cancer.